Xiongwen Lv

anhui medical university

H指数:0

被引数:0

浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Emerging importance of m6A modification in liver cancer and its potential therapeutic role

m6A修饰在肝癌中新兴的重要性及其潜在的治疗作用

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

IF8.3

2025-07-010

PRE

FAM134B-mediated ER-phagy alleviates alcohol-related liver fibrosis by reducing endoplasmic reticulum stress

FAM134B介导的内质网自噬通过减少内质网应激来缓解酒精相关肝纤维化

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2025-05-010

PRE

The novel dual MEK inhibitor ABM-4095 for RAS-mutated lung cancer as a single agent or in combination with known therapies

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-010

PRE

Decoding m6A mRNA methylation by reader proteins in liver diseases

阅读蛋白在肝脏疾病中解码m6A mRNA甲基化

GENES & DISEASES

IF9.4

2024-03-016

OAAI

Emerging role of m6A modification in fibrotic diseases and its potential therapeutic effect

m6A修饰在纤维化疾病中的新兴作用及其潜在治疗效果

BIOCHEMICAL PHARMACOLOGY

IF5.6

2023-12-013

PRE

New insights into fibrotic signaling in hepatocellular carcinoma

肝细胞癌纤维化信号的新见解

FRONTIERS IN ONCOLOGY

IF3.3

2023-11-224

OAAI

Hesperetin derivative 2a inhibits lipopolysaccharide-induced acute liver injury in mice via downregulation of circDcbld2

ACTA PHARMACOLOGICA SINICA

IF8.4

2023-10-161

PRE

The effect of hepatic stellate cell derived-IL-11 on hepatocyte injury in hepatic fibrosis

肝星状细胞derived-IL-11在肝纤维化肝细胞损伤中的作用

LIFE SCIENCES

IF5.1

2023-10-017

PRE

CD73 mitigates hepatic damage in alcoholic steatohepatitis by regulating PI3K/AKT-mediated hepatocyte pyroptosis

BIOCHEMICAL PHARMACOLOGY

IF5.6

2023-09-013

PRE

N6-methyladenosine-modified circIRF2, identified by YTHDF2, suppresses liver fibrosis via facilitating FOXO3 nuclear translocation

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2023-09-0114

PRE

Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis (vol 161, 114472, 2023)

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2023-06-010

OAAI

CD73 aggravates alcohol-related liver fibrosis by promoting autophagy mediated activation of hepatic stellate cells through AMPK/AKT/mTOR signaling pathway

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2022-12-019

OAAI

Inhibition of P2Y6 receptor expression in Kupffer cells alleviates alcoholic steatohepatitis in mice

抑制Kupffer细胞P2Y6受体表达减轻小鼠酒精性脂肪性肝炎

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2022-08-015

PRE

Hepcidin expression levels involve efficacy of pegylated interferon-α treatment in hepatitis B-infected liver

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2022-06-013

PRE

CD73 Attenuates Alcohol-Induced Liver Injury and Inflammation via Blocking TLR4/MyD88/NF-κB Signaling Pathway

CD73通过阻断TLR4/MyD88/nf-κb信号通路减轻酒精性肝损伤和炎症

inflammation research

IF4.1

2022-01-0117

CD39-mediated ATP-adenosine signalling promotes hepatic stellate cell activation and alcoholic liver disease

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2021-08-0121

PREAI

CD73 regulates hepatic stellate cells activation and proliferation through Wnt/β-catenin signaling pathway

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2021-01-0118

PREAI

Chemokine CXCL14 acts as a potential genetic target for liver fibrosis

趋化因子CXCL14作为肝纤维化的潜在遗传靶点

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2020-12-0112

PREAI

LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway

LEFTY2通过调节TGF-β1/Smad3通路减轻肝星状细胞活化和肝纤维化

MOLECULAR IMMUNOLOGY

IF3

2020-10-0124

PREAI

NLRC5 negatively regulates inflammatory responses in LPS-induced acute lung injury through NF-κB and p38 MAPK signal pathways

NLRC5通过nf-κb和p38 MAPK信号通路负调控LPS诱导的急性肺损伤炎症反应

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2020-09-0128

PREAI

Xiongwen Lv

个人简介

教育背景

工作经历

荣誉奖项

研究方向